LABP stock is up on acquisition news Landos Biopharma (NASDAQ:LABP) stock is on the rise Monday after the company announced an acquisition deal with AbbVie (NYSE:ABBV). AbbVie is acquiring Landos Biopharma for $20.42 per share in cash. That represents a roughly 160.8% premium over the stock’s…
#labp #landosbiopharma #abbvie #roopalthakkar #ocugen #tesla #williamwhite
Continue reading...